Clinical Trial Update: Clinical Trial of Autologous Intravitreal Bone-marrow CD34+ Stem Cells for Retinopathy [Phase 1]

View source ↗

Summary

Phase 1 trial update on autologous intravitreal CD34+ stem cells for retinopathy; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration
• Diabetic Retinopathy
• Hereditary Macular Degeneration
• Retinal Vein Occlusion
• Retinitis Pigmentosa

Drugs mentioned

• Autologous Intravitreal Bone-marrow CD34+ Stem Cells (CD34+ stem cells from autologous bone marrow)

Snippet

Sponsor: University of California, Davis | Conditions: Non-exudative Age-related Macular Degeneration, Diabetic Retinopathy | Phase 1 | Status: ACTIVE_NOT_RECRUITING